CD8A and neoplasm: In the OC‐bearing mice model, mini DCs stimulated the production abundant of CD3+CD8+ T cells and reduced CD4+ CD25+ Foxp3+ regulatory T cell (Treg) levels to inhibit tumor growth after mini DCs administration.